Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Satoshi Ebata

11PUBLICATIONS
11CO-AUTHORS
Neurology and neuromuscular diseasesPredictive and prognostic markersBiomolecular modelling and designAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Aug 12, 2022
New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics.

Satoshi Ebata, Asako Yoshizaki-Ogawa, Shinichi Sato

|May 28, 2022
Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration.

Ruriko Kawanabe, Ayumi Yoshizaki, Kazuki M Matsuda

|Feb 09, 2022
Predictors of rituximab effect on modified Rodnan skin score in systemic sclerosis: a machine-learning analysis of the DesiReS trial.

Satoshi Ebata, Koji Oba, Kosuke Kashiwabara

|Dec 24, 2021
Increased Red Blood Cell Distribution Width in the First Year after Diagnosis Predicts Worsening of Systemic Sclerosis-Associated Interstitial Lung Disease at 5 Years: A Pilot Study.

Satoshi Ebata, Ayumi Yoshizaki, Takemichi Fukasawa

|Oct 18, 2021
Percentage of residual B cells after 2 weeks of rituximab treatment predicts the improvement of systemic sclerosis-associated interstitial lung disease.

Satoshi Ebata, Ayumi Yoshizaki, Takemichi Fukasawa

|May 06, 2021
B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis.

Hiroko Numajiri, Ai Kuzumi, Takemichi Fukasawa

Pageof 2

Frequent Collaborators

8 joint publications

Ayumi Yoshizaki

4 joint publications

Takemichi Fukasawa

3 joint publications

Kazuki Mitsuru Matsuda

3 joint publications

Ai Kuzumi

2 joint publications

Asako Yoshizaki-Ogawa

2 joint publications

Shinichi Sato

1 joint publications

Hirohito Kotani

1 joint publications

Maiko Fukayama

1 joint publications

Koji Oba

1 joint publications

Ruriko Kawanabe

Frequent Collaborators

8 joint publications

Ayumi Yoshizaki

4 joint publications

Takemichi Fukasawa

3 joint publications

Kazuki Mitsuru Matsuda

3 joint publications

Ai Kuzumi

Top Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on : Jun 16, 2020

20.1K
Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on : Jun 26, 2018

9.6K
See more related videos

Top Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on : Jun 16, 2020

20.1K
Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on : Jun 26, 2018

9.6K
See more related videos